LAKEFRONT BIOTHERAPEUTICS NV Lakefront received a transparency notification that Bank of America's holding fell below 10% after a disposal of its voting rights; a shareholder sell-down with no stated operational cause.
Lakefront Biotherapeutics NV received a transparency notification from Bank of America Corporation after the bank's holding fell below 10% of the company's voting rights. According to the notification, Bank of America crossed below the 10% threshold on October 2, 2026, following a disposal of Lakefront voting rights and equivalent financial instruments, with the notification dated October 6, 2026. As of October 2, Bank of America Corporation, including its affiliates, held 254,604 voting rights and 5,371,394 equivalent financial instruments, together representing 8.54% of Lakefront's 65,897,071 currently outstanding shares. After the transaction, direct voting rights stood at 0.39% and equivalent financial instruments at 8.15%. The notification was made under Belgian transparency legislation, and Lakefront is listed on Euronext and NASDAQ under the ticker LKFT.
LAKEFRONT BIOTHERAPEUTICS NV Lakefront received a transparency notification that Bank of America's holding fell below 10% after a disposal of its voting rights; a shareholder sell-down with no stated operational cause.
Bank of America CorpBank of America reduced its stake in Lakefront below the 10% threshold via a disposal of voting rights; a routine portfolio reduction with no clear positive or negative read for BAC.